Findings from a pioneering study in The American Journal of Pathology, published by Elsevier, reveal that administration of the neuropeptide α-melanocyte-stimulating hormone (α-MSH) promotes corneal healing and restores normal eye function to an otherwise degenerating and diseased cornea by providing protection against cell death and promoting cell regeneration.
Roche posts 7% rise in Q3 2023 group sales
Roche noted that the substantial drop in Covid-19 product sales impacted the reduced group sales. Credit: Marlon Trottmann / Shutterstock.com. Roche has posted a 7% rise in
October 20, 2023